Wells Fargo & Company Begins Coverage on DENTSPLY SIRONA (NASDAQ:XRAY)

Analysts at Wells Fargo & Company began coverage on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a research report issued to clients and investors on Friday, MarketBeat Ratings reports. The brokerage set an “equal weight” rating and a $20.00 price target on the medical instruments supplier’s stock. Wells Fargo & Company‘s price objective points to a potential upside of 9.17% from the stock’s current price.

A number of other brokerages have also recently issued reports on XRAY. Robert W. Baird decreased their target price on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a report on Friday, November 8th. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. Mizuho initiated coverage on shares of DENTSPLY SIRONA in a report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 target price on the stock. Leerink Partnrs cut shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Finally, Morgan Stanley cut their price objective on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 17th. Ten investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $25.85.

DENTSPLY SIRONA Stock Down 2.4 %

Shares of NASDAQ XRAY opened at $18.32 on Friday. The stock has a market capitalization of $3.64 billion, a PE ratio of -8.85, a P/E/G ratio of 1.83 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The firm has a fifty day moving average of $19.02 and a 200-day moving average of $21.93. DENTSPLY SIRONA has a 52-week low of $17.21 and a 52-week high of $34.91.

Institutional Trading of DENTSPLY SIRONA

Institutional investors have recently added to or reduced their stakes in the stock. Riverview Trust Co bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth about $26,000. Capital Performance Advisors LLP bought a new stake in DENTSPLY SIRONA in the third quarter valued at about $27,000. MassMutual Private Wealth & Trust FSB raised its stake in DENTSPLY SIRONA by 648.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after buying an additional 1,232 shares in the last quarter. UMB Bank n.a. lifted its holdings in DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after buying an additional 564 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. grew its position in shares of DENTSPLY SIRONA by 700.0% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock worth $33,000 after acquiring an additional 1,568 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.